China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China China Medical System Holdings Ltd. Jun 18, 2024 19:53 JST Read More
ONERHT Foundation's 7th Edition of Annual GAIL Forum Returns on 25 June 2024 at Suntec Singapore ONERHT Foundation Jun 18, 2024 14:30 JST Read More
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India Olympus Jun 12, 2024 10:00 HKT/SGT Read More
FDA Accepts Eisai's Filing of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Eisai Jun 10, 2024 17:50 HKT/SGT Read More
エーザイとバイオジェン、早期アルツハイマー病治療剤「レケンビ(R)」の静注維持投与に関する生物製剤承認一部変更申請が米国FDAにより受理 Eisai Jun 10, 2024 13:00 JST Read More
Eisai Named to List of The Time 100 Most Influential Companies Eisai Jun 03, 2024 16:08 HKT/SGT Read More
Eisai Strengthens Venture Investment Business Aimed at Accelerating Drug Discovery Innovation and Establishment of Ecosystem Platform Eisai Jun 03, 2024 14:22 HKT/SGT Read More
エーザイ、TIME 誌による「最も影響力のある 100 社（TIME100 MOST INFLUENTIAL COMPANIES）」に選定 Eisai Jun 03, 2024 14:00 JST Read More
Fujitsu Japan and Juntendo University launch joint research for disaster-resilient, digital medical system Fujitsu Ltd Jun 03, 2024 10:02 HKT/SGT Read More
Hitachi High-Tech Launches the SU3900SE and SU3800SE Series High-Resolution Schottky Field Emission Scanning Electron Microscopes Allowing Observation of Large and Heavy Samples at the Nano Level Hitachi, Ltd. May 29, 2024 10:30 HKT/SGT Read More
LEQEMBI (lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea Eisai May 28, 2024 14:19 HKT/SGT Read More
Roche and Hitachi High-Tech extend their long-standing partnership Hitachi, Ltd. May 28, 2024 11:53 HKT/SGT Read More
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024 Eisai May 23, 2024 17:07 HKT/SGT Read More
Eisai: Metoject Subcutaneous Injection Pen (Methotrexate) Pen-Type Autoinjector Launched In Japan Eisai May 22, 2024 11:55 HKT/SGT Read More
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status Eisai May 15, 2024 10:19 HKT/SGT Read More
Eisai's Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures Eisai May 13, 2024 16:06 HKT/SGT Read More
Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore Cordlife Group Limited May 09, 2024 18:00 HKT/SGT Read More
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning Fujitsu Ltd May 09, 2024 09:41 HKT/SGT Read More
Q&M Dental Enhances Digital Capabilities by Integrating Align Technology's Newest iTero Lumina(TM) Intraoral Scanner Across Dental Clinics in Singapore Aoxin Q&M Dental Group Ltd May 02, 2024 10:00 HKT/SGT Read More
